Literature DB >> 25282333

Importance of a specific amino acid pairing for murine MLL leukemias driven by MLLT1/3 or AFF1/4.

Alyson A Lokken1, Nicholas J Achille2, Ming-Jin Chang3, Jeffrey J Lin3, Aravinda Kuntimaddi4, Benjamin I Leach4, Bhavna Malik1, Jacqueline B Nesbit3, Shubin Zhang2, John H Bushweller4, Nancy J Zeleznik-Le5, Charles S Hemenway6.   

Abstract

Acute leukemias caused by translocations of the MLL gene at chromosome 11 band q23 (11q23) are characterized by a unique gene expression profile. More recently, data from several laboratories indicate that the most commonly encountered MLL fusion proteins, MLLT1, MLLT3, and AFF1 are found within a molecular complex that facilitates the elongation phase of mRNA transcription. Mutational analyses suggest that interaction between the MLLT1/3 proteins and AFF family proteins are required for experimental transformation of hematopoietic progenitor cells (HPCs). Here, we define a specific pairing of two amino acids that creates a salt bridge between MLLT1/3 and AFF proteins that is critically important for MLL-mediated transformation of HPCs. Our findings, coupled with the newly defined structure of MLLT3 in complex with AFF1, should facilitate the development of small molecules that block this amino acid interaction and interfere with the activity of the most common MLL oncoproteins.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Leukemic transformation; Mutation complementation; Oncoproteins; Protein binding

Mesh:

Substances:

Year:  2014        PMID: 25282333      PMCID: PMC4253547          DOI: 10.1016/j.leukres.2014.08.010

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  17 in total

1.  Dot1a-AF9 complex mediates histone H3 Lys-79 hypermethylation and repression of ENaCalpha in an aldosterone-sensitive manner.

Authors:  Wenzheng Zhang; Xuefeng Xia; Mary Rose Reisenauer; Charles S Hemenway; Bruce C Kone
Journal:  J Biol Chem       Date:  2006-04-24       Impact factor: 5.157

2.  A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification.

Authors:  Dorothee Mueller; Christian Bach; Deniz Zeisig; Maria-Paz Garcia-Cuellar; Sara Monroe; Arun Sreekumar; Rong Zhou; Alexey Nesvizhskii; Arul Chinnaiyan; Jay L Hess; Robert K Slany
Journal:  Blood       Date:  2007-09-12       Impact factor: 22.113

3.  AF5q31, a newly identified AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia with ins(5;11)(q31;q13q23).

Authors:  T Taki; H Kano; M Taniwaki; M Sako; M Yanagisawa; Y Hayashi
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

4.  Mouse Af9 is a controller of embryo patterning, like Mll, whose human homologue fuses with Af9 after chromosomal translocation in leukemia.

Authors:  Emma C Collins; Alexandre Appert; Linda Ariza-McNaughton; Richard Pannell; Yoshihiro Yamada; Terence H Rabbitts
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

5.  Structure of the MLL CXXC domain-DNA complex and its functional role in MLL-AF9 leukemia.

Authors:  Tomasz Cierpicki; Laurie E Risner; Jolanta Grembecka; Stephen M Lukasik; Relja Popovic; Monika Omonkowska; David D Shultis; Nancy J Zeleznik-Le; John H Bushweller
Journal:  Nat Struct Mol Biol       Date:  2009-12-13       Impact factor: 15.369

6.  The synthetic peptide PFWT disrupts AF4-AF9 protein complexes and induces apoptosis in t(4;11) leukemia cells.

Authors:  R S Srinivasan; J B Nesbit; L Marrero; F Erfurth; V F LaRussa; C S Hemenway
Journal:  Leukemia       Date:  2004-08       Impact factor: 11.528

7.  A role for MEIS1 in MLL-fusion gene leukemia.

Authors:  Ashish R Kumar; Quanzhi Li; Wendy A Hudson; Weili Chen; Thien Sam; Qing Yao; Erik A Lund; Baolin Wu; Branden J Kowal; John H Kersey
Journal:  Blood       Date:  2008-12-24       Impact factor: 22.113

8.  Leukemia fusion target AF9 is an intrinsically disordered transcriptional regulator that recruits multiple partners via coupled folding and binding.

Authors:  Benjamin I Leach; Aravinda Kuntimaddi; Charles R Schmidt; Tomasz Cierpicki; Stephanie A Johnson; John H Bushweller
Journal:  Structure       Date:  2012-12-20       Impact factor: 5.006

9.  The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling.

Authors:  Emmanuelle Bitoun; Peter L Oliver; Kay E Davies
Journal:  Hum Mol Genet       Date:  2006-11-29       Impact factor: 6.150

10.  Misguided transcriptional elongation causes mixed lineage leukemia.

Authors:  Dorothee Mueller; María-Paz García-Cuéllar; Christian Bach; Sebastian Buhl; Emanuel Maethner; Robert K Slany
Journal:  PLoS Biol       Date:  2009-11-24       Impact factor: 8.029

View more
  3 in total

1.  Degree of recruitment of DOT1L to MLL-AF9 defines level of H3K79 Di- and tri-methylation on target genes and transformation potential.

Authors:  Aravinda Kuntimaddi; Nicholas J Achille; Jeremy Thorpe; Alyson A Lokken; Ritambhara Singh; Charles S Hemenway; Mazhar Adli; Nancy J Zeleznik-Le; John H Bushweller
Journal:  Cell Rep       Date:  2015-04-23       Impact factor: 9.423

2.  BCOR Binding to MLL-AF9 Is Essential for Leukemia via Altered EYA1, SIX, and MYC Activity.

Authors:  Charles R Schmidt; Nicholas J Achille; Aravinda Kuntimaddi; Adam M Boulton; Benjamin I Leach; Shubin Zhang; Nancy J Zeleznik-Le; John H Bushweller
Journal:  Blood Cancer Discov       Date:  2020-09

Review 3.  The Intrinsically Disordered Proteins MLLT3 (AF9) and MLLT1 (ENL) - Multimodal Transcriptional Switches With Roles in Normal Hematopoiesis, MLL Fusion Leukemia, and Kidney Cancer.

Authors:  Ashish Kabra; John Bushweller
Journal:  J Mol Biol       Date:  2021-06-23       Impact factor: 5.469

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.